Interstitial Lung Disease | Oncology Today with Dr Neil Love: Interstitial Lung Disease in Patients Receiving Anticancer Therapy

Featuring an interview with Dr Charles Powell, including the following topics: Role of the pulmonologist in the cancer care team; frequency of fatal and Grade 4 interstitial lung disease (ILD) with antibody-drug conjugates (0:00) Pathophysiology of pneumonitis associated with checkpoint inhibitors versus antibody-drug conjugates; differences in presentation of ILD based on the cause of disease (8:04) Myths and misperceptions about drug-related pneumonitis among general medical oncologists (14:08) Monitoring for the onset of ILD using remote technology; typical time to onset of ILD (21:45) Risk factors for the development of ILD among patients receiving anticancer therapy (25:58) Incidence of ILD with bispecific antibodies; mechanisms underlying differences in the incidence of ILD associated with various antibody-drug conjugates (33:45) CME information and select publications